Beta Bionics outlines $130M-$135M 2026 revenue target while expanding sales force and pharmacy channel
Source: SeekingAlpha
2026-02-18 01:15:48 ET
More on Beta Bionics
- Beta Bionics, Inc. (BBNX) Q4 2025 Earnings Call Transcript
- Beta Bionics: It Has Been An Interesting Year
- Beta Bionics GAAP EPS of -$0.30 beats by $0.10, revenue of $32.1M beats by $1.03M
- Beta Bionics reports Strong Preliminary Q4 2025 Topline Growth
- Seeking Alpha’s Quant Rating on Beta Bionics
Read the full article on Seeking Alpha
For further details see:
Beta Bionics outlines $130M–$135M 2026 revenue target while expanding sales force and pharmacy channel
Beta Bionics Inc.
NASDAQ: BBNX
BBNX Trading
2.38% G/L:
$10.31 Last:
323,582 Volume:
$10.20 Open:
BBNX Latest News
February 19, 2026 04:05:00 pm
Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
BBNX Stock Data
$650,684,046
33,810,917
0.48%
38
N/A
Medical Equipment & Supplies
Healthcare
US
Irvine
